209 related articles for article (PubMed ID: 29345293)
1. S100B expression in breast cancer as a predictive marker for cancer metastasis.
Yen MC; Huang YC; Kan JY; Kuo PL; Hou MF; Hsu YL
Int J Oncol; 2018 Feb; 52(2):433-440. PubMed ID: 29345293
[TBL] [Abstract][Full Text] [Related]
2. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
3. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.
Wang XX; Zhu Z; Su D; Lei T; Wu X; Fan Y; Li X; Zhao J; Fu L; Dong JT; Fu L
Hum Pathol; 2011 Oct; 42(10):1410-9. PubMed ID: 21419475
[TBL] [Abstract][Full Text] [Related]
5. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
Baghi N; Bakhshinejad B; Keshavarz R; Babashah S; Sadeghizadeh M
Gene; 2018 Sep; 670():55-62. PubMed ID: 29753810
[TBL] [Abstract][Full Text] [Related]
6. S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53.
Yang T; Cheng J; You J; Yan B; Liu H; Li F
Oncol Rep; 2018 Sep; 40(3):1574-1582. PubMed ID: 29956807
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
8. Serum S100B Levels in Melanoma.
Frauchiger AL; Dummer R; Mangana J
Methods Mol Biol; 2019; 1929():691-700. PubMed ID: 30710305
[TBL] [Abstract][Full Text] [Related]
9. NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.
Xu X; Yan Q; Wang Y; Dong X
Oncol Rep; 2017 Jan; 37(1):449-457. PubMed ID: 27840993
[TBL] [Abstract][Full Text] [Related]
10. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
[TBL] [Abstract][Full Text] [Related]
11. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
[TBL] [Abstract][Full Text] [Related]
12. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
13. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
14. Interrelationship of serum S100B and P53 in brain tumour patients.
Syeda T; Rizvi HA; Hadi SM; M Hashim AS; Khan MH
J Pak Med Assoc; 2016 Jun; 66(6):748-50. PubMed ID: 27339581
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
[TBL] [Abstract][Full Text] [Related]
16. Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue.
Seguella L; Rinaldi F; Marianecci C; Capuano R; Pesce M; Annunziata G; Casano F; Bassotti G; Sidoni A; Milone M; Aprea G; de Palma GD; Carafa M; Pesce M; Esposito G; Sarnelli G
J Cell Mol Med; 2020 Mar; 24(5):3053-3063. PubMed ID: 32022398
[TBL] [Abstract][Full Text] [Related]
17. A search for inhibitors of S100B, a member of the S100 family of calcium-binding proteins.
Markowitz J; MacKerell AD; Weber DJ
Mini Rev Med Chem; 2007 Jun; 7(6):609-16. PubMed ID: 17584159
[TBL] [Abstract][Full Text] [Related]
18. Lack of elevation of serum S100B in patients with metastatic melanoma as a predictor of outcome after induction with an autologous vaccine of proliferating tumor cells and dendritic cells.
Schiltz PM; Dillman RO; Korse CM; Cubellis JM; Lee GJ; De Gast GC
Cancer Biother Radiopharm; 2008 Apr; 23(2):214-21. PubMed ID: 18454690
[TBL] [Abstract][Full Text] [Related]
19. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells.
Lin J; Yang Q; Yan Z; Markowitz J; Wilder PT; Carrier F; Weber DJ
J Biol Chem; 2004 Aug; 279(32):34071-7. PubMed ID: 15178678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
